IL7R and lymphoma: So far, researches of IL7R in hematological malignancies have been mainly focused on acute lymphoblastic leukemia (ALL) and lymphoma, in which the prognostic impact was contradictory; several studies reported that IL7R is highly expressed and an upregulation of IL7R may predict relapse (21, 22), whereas Cleaver et al.